| abstract |
PROBLEM TO BE SOLVED: To provide an improved therapeutic agent and a therapeutic method for immunoinflammatory diseases, ophthalmic diseases, musculoskeletal disorders or pain associated therewith, periodontal diseases, or diseases associated with elevated serum CRP levels. Treatment of an immunoinflammatory disease, ophthalmic disease, musculoskeletal disorder or associated pain, periodontal disease, or a disease or condition associated with elevated serum CRP levels upon administration to a patient in need of treatment A composition comprising a drug pair selected from a particular pair in a sufficient amount. [Selection figure] None |